Physician profile
Robert Steven Westrol
NPI 1497796916
$5,268.86
in general payments reported to CMS, 2019-2025
18 companies · $605 in 2025
The $605 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $826 · 2021: $503 · 2022: $695 · 2023: $1,239 · 2024: $1,010 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,641 · Travel and Lodging: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,641.13 |
| Travel and Lodging | $213.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,521.80 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,008.52 | 2019-2024 | |
| Spr Therapeutics, INC | $529.25 | 2020-2025 | Sprint Pns System |
| Abbott Laboratories | $397.74 | 2020-2023 | Proclaim, Eterna, Octrode |
| Forte Bio-Pharma LLC | $291.00 | 2020-2024 | Prolate, Nalocet |
| Collegium Pharmaceutical, INC. | $220.10 | 2020-2024 | Belbuca |
| Vertex Pharmaceuticals Incorporated | $48.22 | 2024 | |
| Averitas Pharma INC. | $40.25 | 2023-2024 | Qutenza |
| Medtronic USA, INC. | $39.14 | 2019-2020 | |
| Curonix LLC | $29.96 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $28.95 | 2020-2022 | |
| Pacira Therapeutics, INC. | $27.56 | 2021 | |
| Biocompatibles, INC. | $20.33 | 2019 | |
| Scilex Pharmaceuticals INC. | $18.72 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.61 | 2023 | Relistor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $15.04 | 2019 | |
| Bioventus LLC | $12.89 | 2022 | |
| Electronic Waveform Lab, INC. | $2.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Westrol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.